Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_assertion description "[The endothelin (ET) axis, which includes ET-1, ET-2, ET-3, and 2 G protein-coupled receptor subtypes, ET AR and ET BR, promotes growth and progression of a variety of tumors, such as prostatic, ovarian, renal, pulmonary, colorectal, cervical, breast, lung, bladder, endometrial carcinoma, Kaposi's sarcoma, brain tumors, and melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_assertion evidence source_evidence_literature NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_assertion SIO_000772 18758494 NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_assertion wasDerivedFrom befree-20150227 NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_assertion wasGeneratedBy ECO_0000203 NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.
- befree-20150227 importedOn "2015-02-27" NP226489.RAVdcGqpP1kxNASJv27vXCJOgAFlPbgouX2Fm3MNOK0As130_provenance.